UPDATE 3-Takeda to buy Swiss drugmaker Nycomed for $13.6 bln

some delays, it won U.S. approval in March where Forest Laboratories has the marketing rights. In Europe, Merck & Co has marketing rights. Deutsche Bank acted as financial advisor to Takeda while Goldman Sachs and Credit Suisse acted as financial...